Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Skin-derived stem cells could help treat skin aging and pigmentation issues.

Higher cholesterol levels increase aggressive prostate cancer risk.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Laminin-511 is crucial for early hair growth and maintaining important hair development signals.

Metal organic frameworks-based scaffolds show promise for tissue repair due to their unique properties.

Vimentin is crucial for wound healing, cell growth, and managing immune responses.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Activating TRPV1 can boost hair growth by involving neurons, macrophages, and fibroblasts.

Thymosin Beta 4 helps human dental pulp cells develop into tooth-forming cells, suggesting it could aid dental regeneration.

New methods to test hair growth treatments have been developed.

Bee venom can help stem cells promote hair growth.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Vitamin D receptor and hairless protein are essential for hair growth.

Targeting blood vessels may help treat skin diseases.

Combining specific inducers helps dermal papilla cells regain hair-forming ability.

Bacterial cellulose is a promising material for biomedical uses but needs improvements in antimicrobial properties and degradation rate.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

BFNB could be a promising treatment for hair growth.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

Moracin M helps hair grow by activating specific pathways and improving blood vessel formation.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Mesenchymal stem cells can help repair body tissues with low risk of rejection.

Wound healing is a complex, multi-phase process involving various cells and activities to repair skin damage.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

HOXC13 is crucial for regulating hair keratin genes in hair follicles.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.